EQT
47
13
JBHT
46
4
MSFT
55
2
WU
26
2
DVA
62
5
MKC
54
3
UPS
51
6
SIG
52
5
CAH
44
7
HBI
53
4
L
54
5
ABBV
40
5
AMP
43
2
FITB
36
3
EQR
33
6
CHRW
53
2
EMC
30
-26
PBI
30
-8
FOXA
67
5
WM
53
2
EQT
47
13
JBHT
46
4
MSFT
55
2
WU
26
2
DVA
62
5
MKC
54
3
UPS
51
6
SIG
52
5
CAH
44
7
HBI
53
4
L
54
5
ABBV
40
5
AMP
43
2
FITB
36
3
EQR
33
6
CHRW
53
2
EMC
30
-26
PBI
30
-8
FOXA
67
5
WM
53
2
Financhill
Back

Atara Biotherapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
37

ATRA
Atara Biotherapeutics

Last Price:
$11.27
Seasonality Move:
4.11%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
37
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy, Sell or Hold?

  • The current Atara Biotherapeutics [ATRA] share price is $11.40. The Score for ATRA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATRA Stock Price Chart

What is Atara Biotherapeutics's stock price today?

  • The Atara Biotherapeutics share price today is $11.40
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ATRA is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

ATRA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 51.71 Buy
Chaikin Money Flow: 138596 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.63 - 12.55) Sell
Bollinger Bands (100): (7.42 - 11.18) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

ATRA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.65 Buy
20-day SMA: 11.71 Sell
50-day SMA: 10.72 Buy
200-day SMA: 11.74 Sell
8-day EMA: 10.84 Buy
20-day EMA: 11.22 Buy
50-day EMA: 10.77 Buy
200-day EMA: 14.19 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $11.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $61.17 per share, and a decrease next year of $10.45 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Atara Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):